BACKGROUND: Anxiety disorders are a group of various mental syndromes that have been related with generally poor treatment response. Several psychological factors may improve or hinder treatment effectiveness. Hope has a direct impact on the effectiveness of psychotherapy. Also, dissociation is a significant factor influencing treatment efficiency in this group of disorders. Development of self-stigma could decrease treatment effectiveness, as well as several temperamental and character traits. The aim of this study was to explore a relationship between selected psychological factors and treatment efficacy in anxiety disorders. SUBJECTS AND METHODS: A total of 109 inpatients suffering from anxiety disorders with high frequency of comorbidity with depression and/or personality disorder were evaluated at the start of the treatment by the following scales: the Mini-International Neuropsychiatric Interview, the Internalized Stigma of Mental Illness scale, the Adult Dispositional Hope Scale, and the Temperament and Character Inventory - revised. The participants, who sought treatment for anxiety disorders, completed the following scales at the beginning and end of an inpatient-therapy program: Clinical Global Impression (objective and subjective) the Beck Depression Inventory - second edition, the Beck Anxiety Inventory, and the Dissociative Experiences Scale. The treatment consisted of 25 group sessions and five individual sessions of cognitive behavioral therapy or psychodynamic therapy in combination with pharmacotherapy. There was no randomization to the type of group-therapy program. RESULTS: Greater improvement in psychopathology, assessed by relative change in objective Clinical Global Impression score, was connected with low initial dissociation level, harm avoidance, and self-stigma, and higher amounts of hope and self-directedness. Also, individuals without a comorbid personality disorder improved considerably more than comorbid patients. According to backward-stepwise multiple regression, the best significant predictor of treatment effectiveness was the initial level of self-stigma. CONCLUSION: The initial higher levels of self-stigma predict a lower effectiveness of treatment in resistant-anxiety-disorder patients with high comorbidity with depression and/or personality disorder. The results suggest that an increased focus on self-stigma during therapy could lead to better treatment outcomes.

Department of Psychiatry Olomouc University Hospital Faculty of Medicine and Dentistry Palacký University Olomouc Czech Republic

Zobrazit více v PubMed

Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19. PubMed

Hooke GR, Page AC. Predicting outcomes of group cognitive behavior therapy for patients with affective and neurotic disorders. Behav Modif. 2006;26:648–659. PubMed

Pohl RB, Feltner DE, Fieve RR, Pande AC. Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing. J Clin Psychopharmacol. 2005;25:151–158. PubMed

Heldt E, Manfro GG, Kipper L, et al. Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital. Psychother Psychosom. 2003;72:43–48. PubMed

Tyrer P, Seivewright H, Johnson T. The Nottingham study of neurotic disorder: predictors of 12-year outcome of dysthymic, panic, and generalized anxiety disorder. Psychol Med. 2004;34:1385–1394. PubMed

Linden M, Zubraegel D, Baer T, Franke U, Schlattmann P. Efficacy of cognitive behaviour therapy in generalized anxiety disorders: results of a controlled clinical trial (Berlin CBT-GAD study) Psychother Psychosom. 2005;74:36–42. PubMed

National Collaborating Centre for Mental Health (UK) Generalized Anxiety Disorder in Adults: Management in Primary, Secondary, and Community Care. Leicester (UK): British Psychological Society; 2011. PubMed

Zou C, Ding X, Flaherty JH, Dong B. Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients. Neuropsychiatr Dis Treat. 2013;9:1661–1670. PubMed PMC

Pelissolo A. Efficacy and tolerability of escitalopram in anxiety disorders: a review. Encephale. 2008;34:400–408. French. PubMed

Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress, and obsessive-compulsive disorders. BMC Psychiatry. 2014;14(Suppl 1):S1. PubMed PMC

Prasko J, Kamaradova D, Cakirpaloglu S, et al. Predicting the therapeutic response to intensive psychotherapeutic programs in patients with neurotic spectrum disorders. Act Nerv Super Rediviva. 2015;57:30–39.

Mululo SC, Menezes GB, Vigne P, Fontenelle LF. A review on predictors of treatment outcome in social anxiety disorder. Rev Bras Psiquiatr. 2012;34:92–100. PubMed

Schat A, van Noorden MS, Noom MJ, et al. Predictors of outcome in outpatients with anxiety disorders: the Leiden routine outcome monitoring study. J Psychiatr Res. 2013;47:1876–1885. PubMed

El Alaoui S, Ljótsson B, Hedman E, et al. Predictors of symptomatic change and adherence in internet-based cognitive behaviour therapy for social anxiety disorder in routine psychiatric care. PLoS One. 2015;10:e0124258. PubMed PMC

Mennin DS, Heimberg RG. The impact of comorbid mood and personality disorders in the cognitive-behavioral treatment of panic disorder. Clin Psychol Rev. 2000;20:339–357. PubMed

Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry. 2004;161:2108–2114. PubMed

Prasko J, Raszka M, Adamcova K, et al. Predicting the therapeutic response to cognitive behavioural therapy in patients with pharmacoresistant obsessive-compulsive disorder. Neuro Endocrinol Lett. 2009;30:615–623. PubMed

Ociskova M, Prasko J, Kamaradova D, Grambal A, Latalova K, Sigmundova Z. The relationship between internalized stigma and treatment efficacy in the mixed neurotic spectrum and depressive disorders. Neuroendocrinol Lett. 2014;35:711–717. PubMed

Watson S, Chilton R, Fairchild H, Whewell P. Association between childhood trauma and dissociation among patients with borderline personality disorder. Aust N Z J Psychiatry. 2006;40:478–481. PubMed

Ross CA. Borderline personality disorder and dissociation. J Trauma Dissociation. 2007;8:71–80. PubMed

Dell PF, O’Neil JA. Dissociation and the Dissociative Disorders: DSM-V and Beyond. New York: Routledge; 2009.

Bob P. Dissociative symptoms and their measurement. Ceska Slov Psychiatr. 2000;6:301–309. Czech.

Gulsun M, Doruk A, Uzun O, Turkbay T, Ozsahin A. Effect of dissociative experiences on drug treatment of panic disorder. Clin Drug Investig. 2007;27:583–590. PubMed

Pastucha P, Prasko J, Grambal A, et al. Panic disorder and dissociation: comparison with healthy controls. Neuro Endocrinol Lett. 2009;30:774–778. PubMed

Prasko J, Raszka M, Diveky T, et al. Obsessive compulsive disorder and dissociation: comparison with healthy controls. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154:179–183. PubMed

Bremner JD, Brett E. Trauma-related dissociative states and long-term psychopathology in posttraumatic stress disorder. J Trauma Stress. 1997;10:37–49. PubMed

Zlotnick C, Shea MT, Pearlstein T, Simpson E, Costello E, Begin A. The relationship between dissociative symptoms, alexithymia, impulsivity, sexual abuse, and self-mutilation. Compr Psychiatry. 1996;37:12–16. PubMed

Irving LM, Snyder CR, Cheavens J, et al. The relationship between hope and outcomes at the pretreatment, beginning, and later phases of psychotherapy. J Psychother Integr. 2004;14:419–443.

Rugens A, Terhune DB. Guilt by dissociation: guilt primes augment the relationship between dissociative tendencies and state dissociation. Psychiatry Res. 2013;206:114–116. PubMed

Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol. 2001;27:363–385.

Ball S, Robinson A, Shekhar A, Walsh K. Dissociative symptoms in panic disorder. J Nerv Ment Dis. 1997;185:755–760. PubMed

Seguí J, Márquez M, García L, Canet J, Salvador-Carulla L, Ortiz M. Depersonalization in panic disorder: a clinical study. Compr Psychiatry. 2000;41:172–178. PubMed

Praško J, Raszka M, Adamcová K, Kopřivová J, Kudrnovská H, Vyskočilová J. Prediction of therapeutic response in patients suffering from obsessive compulsive disorder resistant to the treatment with psychopharmacs. Psychiatrie (Stuttg) 2008;12(Suppl 3):55–62. Czech.

Raszka M, Praško J, Adamcová K, Kopřivová J, Vyskočilová J. Dissociation and cognitive function in obsessive compulsive disorder: cross sectional study. Ceska Slov Psychiatr. 2008;104:298–296. Czech.

Spitzer C, Barnow S, Freyberger HJ, Grabe HJ. Dissociation predicts symptom-related treatment outcome in short-term inpatient psychotherapy. Aust N Z J Psychiatry. 2007;41:682–687. PubMed

Snyder CR. Handbook of Hope: Theory, Measures, and Applications. San Diego: Academic Press; 2000.

Snyder CR, Sympson SC, Ybasco FC, Borders TF, Babyak MA, Higgins RL. Development and validation of the State Hope Scale. J Pers Soc Psychol. 1996;70:321–335. PubMed

Snyder CR, Harris C, Anderson JR, et al. The will and the ways: development and validation of an individual-differences measure of hope. J Pers Soc Psychol. 1991;60:570–585. PubMed

Snyder CR, Hoza B, Pelham WE, et al. The development and validation of the Children’s Hope Scale. J Pediatr Psychol. 1997;22:399–421. PubMed

Mathis GM, Ferrari JR, Groh DR, Jason LA. Hope and substance abuse recovery: the impact of agency and pathways within an abstinent communal-living setting. J Groups Addict Recover. 2009;4:42–50. PubMed PMC

Geraghty AW, Wood AM, Hyland ME. Dissociating the facets of hope: agency and pathways predict dropout unguided self-help therapy in opposite directions. J Res Pers. 2010;44:155–158.

Snyder CR, Ilardi SS, Cheavens J, Michael ST, Yamhure L, Sympson S. The role of hope in cognitive-behavioral therapies. Cognit Ther Res. 2000;24:747–762.

Perry BM, Taylor D, Shaw SK. “You’ve got to have a positive state of mind”: an interpretative phenomenological analysis of hope and first episode psychosis. J Ment Health. 2007;16:781–793.

Cheavens JS, Feldman DB, Gum A, Michael ST, Snyder CR. Hope therapy in a community sample: a pilot investigation. Soc Indic Res. 2006;77:61–78.

Benzein E, Norberg A, Saveman BI. The meaning of the lived experience of hope in patients with cancer palliative home care. Palliat Med. 2001;15:117–126. PubMed

Lin HR, Bauer-Wu SM. Psycho-spiritual well-being in patients with advanced cancer: an integrative review of literature. J Adv Nurs. 2003;44:69–80. PubMed

Shekarabi-Ahari G, Younesi J, Borjali A, Ansari-Damavandi S. The effectiveness of group hope therapy on hope and depression of mothers with children suffering from cancer in Tehran. Iran J Cancer Prev. 2012;5:183–188. PubMed PMC

Neenan M, Dryden W. Cognitive Behaviour Therapy. London: Sage; 2002.

Kwon P. Hope and dysphoria: the moderating role of defense mechanisms. J Pers. 2000;68:199–223. PubMed

Yanos PT, Roe D, Markus K, Lysaker PH. Pathways between internalized stigma and outcomes related to recovery in schizophrenia spectrum disorders. Psychiatr Serv. 2008;59:1437–1442. PubMed PMC

Ociskova M, Prasko J, Kamaradova D. Relationship between personality and self-stigma in the mixed neurotic spectrum and depressive disorders: a cross-sectional study. Act Nerv Super Rediviva. 2015;57:22–29.

Fung KM, Tsang HW, Chan F. Self-stigma, stages of change and psychosocial treatment adherence among Chinese people with schizophrenia: a path analysis. Soc Psychiatry Psychiatr Epidemiol. 2010;45:561–568. PubMed

Goffman E. Stigma: Notes on the Management of Spoiled Identity. New York: Simon & Schuster; 1963.

Padurariu M, Ciobica A, Persson C, Stefanescu C. Self-stigma in psychiatry: ethical and bio-psycho-social perspectives. Rev Rom Bioet. 2011;9:76–82.

Corrigan PW, Rafacz J, Rüsch N. Examining a progressive model of self-stigma and its impact on people with serious mental illness. Psychiatry Res. 2011;189:339–343. PubMed PMC

Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med. 2010;71:2150–2161. PubMed

Alonso J, Buron A, Bruffaerts R, et al. Association of perceived stigma and mood and anxiety disorders: results from the World Mental Health Surveys. Acta Psychiatr Scand. 2008;118:305–314. PubMed PMC

Ritsher JB, Phelan JC. Internalized stigma predicts erosion of morale among psychiatric outpatients. Psychiatry Res. 2004;129:257–265. PubMed

Mosanya TJ, Adelufosi AO, Adebowale OT, Oqunwale A, Adebayo OK. Self-stigma, quality of life and schizophrenia: an outpatient clinic survey in Nigeria. Int J Soc Psychiatry. 2014;60:377–386. PubMed

Cinculova A, Kamaradova D, Ociskova M, et al. Self-stigma, treatment adherence, and medication discontinuation in anxiety disorders: a cross-sectional study. Ceska Slov Psychiatr. 2015;111:577–583. Czech.

Vrbová K, Kamarádová D, Látalová K, et al. Self-stigma and adherence to medication in patients with psychotic disorders: cross-sectional study. Neuro Endocrinol Lett. 2014;35:645–652. PubMed

Hajda M, Kamaradova D, Latalova K, et al. Self-stigma, treatment adherence, and medication discontinuation in patients with bipolar disorders in remission: a cross-sectional study. Act Nerv Super Rediviva. 2015;57:6–11.

Latalova K, Prasko J, Kamaradova D, et al. Self-stigma and suicidality in patients with neurotic spectrum disorder: a cross sectional study. Neuro Endocrinol Lett. 2014;35:474–480. PubMed

Brohan E, Elgie R, Sartorius N, Thornicroft G. Self-stigma, empowerment and perceived discrimination among people with schizophrenia in 14 European countries: the GAMIAN-Europe study. Schizophr Res. 2010;122:232–238. PubMed

Bathje GJ, Pryor JB. The relationships of public and self-stigma to seeking mental health services. J Ment Health Couns. 2011;33:161–176.

Simonds LM, Thorpe SJ. Attitudes towards obsessive compulsive disorders: an experimental investigation. Soc Psychiatry Psychiatr Epidemiol. 2003;38:331–336. PubMed

Brohan E, Gauci D, Sartorius N, Thornicroft G. Self-stigma, empowerment and perceived discrimination among people with bipolar disorder or depression in 13 European countries: the GAMIAN-Europe study. J Affect Disord. 2010;129:56–63. PubMed

Link BG, Struening EL, Rahav M, Phelan JC, Nuttbrock L. On stigma and its consequences: evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. J Health Soc Behav. 1997;38:177–190. PubMed

Kamaradova D, Latalova K, Prasko J, et al. Self-stigma, adherence, and withdrawal of the medication in psychiatric disorders: a cross-sectional study. Psychiatrie (Stuttg) 2015;19:175–183. Czech.

Yen CF, Chen CC, Lee Y, Tang TC, Yen JY, Ko CH. Self-stigma and its correlates among outpatients with depressive disorders. Psychiatr Serv. 2005;56:599–601. PubMed

Camp DL, Finlay WM, Lyons E. Is low self-esteem inevitable consequence of stigma? An example from women with chronic mental health problems. Soc Sci Med. 2002;55:823–834. PubMed

Corchs F, Corregiari F, Ferrão YA, et al. Personality traits and treatment outcome in obsessive-compulsive disorder. Rev Bras Psiquiatr. 2008;30:246–250. PubMed

Anderson CB, Joyce PR, Carter FA, McIntosh VV, Bulik CM. The effect of cognitive-behavioral therapy for bulimia nervosa on temperament and character as measured by the Temperament and Character Inventory. Compr Psychiatry. 2002;43:182–188. PubMed

Quilty LC, Godfrey KM, Kennedy SH, Begby RM. Harm avoidance as a mediator of treatment response to antidepressant treatment of patients with major depression. Psychother Psychosom. 2010;79:116–122. PubMed

Kampman O, Viikki M, Järventausta K, Leinonen Meta-analysis of anxiety disorders and temperament. Neuropsychobiology. 2014;69:175–186. PubMed

Wachleski C, Salum GA, Blaya C, et al. Harm avoidance and self-directedness as essential features of panic disorder patients. Compr Psychiatry. 2008;49:476–481. PubMed

Margetić BA, Jakovljević M, Ivanec D, Margetić B, Tošić G. Relations of internalized stigma with temperament and character in patients with schizophrenia. Compr Psychiatry. 2010;51:603–606. PubMed

Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 1986;3:167–226. PubMed

Kose S. A psychobiological model of temperament and character: TCI. Yeni Symp. 2003;41:86–97.

Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. quiz 34–57. PubMed

Amorim P. Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentains. Rev Bras Psiquiatr. 2000;22:106–115.

Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res. 2003;121:31–49. PubMed

Ocisková M, Praško J, Kamarádová D, et al. Self-stigma in psychiatric patients: standardization of the ISMI scale. Neuro Endocrinol Lett. 2014;35:624–632. PubMed

Ociskova M, Sobotkova I, Prasko J, Mihal V. Standardizace české verze Škály dispoziční naděje pro dospělé [Standardization of the Adult Dispositional Hope Scale – the Czech version] Psychologie a její kontexty. 2016 In press.

Cloninger CR. The Temperament and Character Inventory (TCI): A Guide to Its Development and Use. St Louis: Centre for Psychobiology of Personality; 1994.

Farmer RF, Goldberg LR. A psychometric evaluation of the revised Temperament and Character Inventory (TCI-R) and the TCI-140. Psychol Assess. 2008;20:281–291. PubMed PMC

Preiss M, Kucharová J, Novák T, Stepánková H. The Temperament and Character Inventory – revised (TCI-R): a psychometric characteristics of the Czech version. Psychiatr Danub. 2007;19:27–34. PubMed

Brändström S, Richter J, Nylander PO. Further development of the Temperament and Character Inventory. Psychol Rep. 2003;93:995–1002. PubMed

Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville (MD): US Department of Health, Education, and Welfare; 1976.

Kadouri A, Corruble E, Falissard B. The improved Clinical Global Impression scale (ICGI): development and validation in depression. BMC Psychiatry. 2007;7:7. PubMed PMC

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–897. PubMed

De Ayala RJ, Vonderharr-Carlson DJ, Kim D. Assessing the reliability of the Beck Anxiety Inventory scores. Educ Psychol Meas. 2005;65:742–756.

Kamaradova D, Prasko J, Latalova K, et al. Psychometric properties of the Czech version of the Beck Anxiety Scale: comparison between diagnostic groups. Neuro Endocrinol Lett. 2016;36:706–712. PubMed

Storch EA, Roberti JW, Roth DA. Factor structure, concurrent validity, and internal consistency of the Beck Depression Inventory – second edition in a sample of college students. Depress Anxiety. 2004;19:187–189. PubMed

Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100.

Preiss M, Vacir K. Beckova Sebeposuzovaci Skala Depresivity pro Dospele: BDI-II. Brno: Psychodiagnostika; 1999.

Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis. 1986;174:727–735. PubMed

Waller NG, Ross CA. The prevalence and biometric structure of pathologic dissociation in the general population: taxometric and behavior genetic findings. J Abnorm Psychol. 1996;106:499–510. PubMed

Ptacek R, Bob P, Paclt I. Dissociative Experiences Scale: the Czech version. Cesk Psychol. 2006;50:262–272. Czech.

Seifertova D, Prasko J, Hoschl C, Horacek J. Postupy v Lecbe Psychickych Poruch. Prague: Academia Medica Pragensis; 2008.

Raboch J, Uhlikova P, Hellerova P, Anders M, Susta P. Psychiatrie: Doporucene Postupy Psychiatricke Pece IV. Prague: Psychiatricka Spolecnost; 2013.

European Medicines Agency Guideline for good clinical practice. 2002. [Accessed May 19, 2016]. Available from: http://www.edctp.org/fileadmin/documents/EMEA_ICH-GCP_Guidelines_July_2002.pdf.

Prasko J, Dockery C, Horace J, et al. Moclobemide and cognitive behavioral therapy in the treatment of social phobia: a six-month controlled study and 24 months follow-up. Neuro Endocrinol Lett. 2006;27:473–481. PubMed

Başoğlu M, Marks IM, Kiliç C, et al. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure. Br J Psychiatry. 1994;164:647–652. PubMed

Van Ameringen M, Mancini C, Pipe B, Bennett M. Optimizing treatment of social phobia: a review of treatment resistance. CNS Spectr. 2004;9:753–762. PubMed

Kamaradova D, Prasko J, Sandoval A, Latalova K. Therapeutic response to complex cognitive-behavioral and pharmacological treatment in patients with social phobia. Act Nerv Super Rediviva. 2014;56:91–99.

Steketee G, Siev J, Fama JM, Keshaviah A, Chosak A, Wilhelm S. Predictors of treatment outcome in modular cognitive therapy for obsessive-compulsive disorder. Depress Anxiety. 2011;28:333–341. PubMed PMC

Overbeek T, Schruers K, Vermetten E, Griez E. Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect. J Clin Psychiatry. 2002;63:1106–1112. PubMed

Telch MJ, Kamphuis JH, Schmidt NB. The effects of comorbid personality disorders on cognitive behavioral treatment for panic disorder. J Psychiatr Res. 2011;45:469–474. PubMed

Thiel N, Hertenstein E, Nissen C, Herbst N, Külz AK, Voderholzer U. The effect of personality disorders on treatment outcomes in patients with obsessive-compulsive disorders. J Pers Disord. 2013;27:697–715. PubMed

Prasko J, Houbová P, Novák T, et al. Influence of personality disorder on the treatment of panic disorder: comparison study. Neuro Endocrinol Lett. 2005;26:667–674. PubMed

Vyskocilova J, Prasko J, Novak T, Pohlova L. Is there any influence of personality disorder on the short term intensive group cognitive behavioral therapy of social phobia? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155:85–94. PubMed

Rufer M, Held D, Cremer J, et al. Dissociation as a predictor of cognitive behavior therapy outcome in patients with obsessive-compulsive disorder. Psychother Psychosom. 2006;75:40–46. PubMed

Self-Stigma and Treatment Effectiveness in Patients with SSRI Non-Responsive Obsessive-Compulsive Disorder

Quality of life, self-stigma, and coping strategies in patients with neurotic spectrum disorders: a cross-sectional study

Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis

Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders - a cross-sectional study

Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study

Self-stigma in borderline personality disorder - cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders